Latest news
TROPION-Breast01 Details Dato-DXd Safety and Patient-Reported Outcomes - OncodailyOncodaily · Sun, 02 Aug 2026 14:54:46 GMTDatroway approved in the EU as only TROP2-directed medicine with overall survival benefit for the 1st-line treatment of patients with metastatic TNBC who are not candidates for immunotherapy - AstraZenecaAstraZeneca · Fri, 31 Jul 2026 02:00:00 GMT